MD Mednax Inc

Price (delayed)

$20.97

Market cap

$1.83B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.55

Enterprise value

$2.69B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The company's EPS has surged by 94% YoY
The debt has decreased by 18% from the previous quarter and by 18% YoY
The net income has surged by 112% year-on-year but it has declined by 30% since the previous quarter
The equity is up by 14% YoY but it is down by 2.2% QoQ
The quick ratio has declined by 18% year-on-year and by 17% since the previous quarter

Key stats

What are the main financial stats of MD
Market
Shares outstanding
87.26M
Market cap
$1.83B
Enterprise value
$2.69B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.07
Price to sales (P/S)
0.92
EV/EBIT
14.97
EV/EBITDA
12.66
EV/Sales
1.38
Earnings
Revenue
$1.95B
EBIT
$179.82M
EBITDA
$212.71M
Free cash flow
$55.83M
Per share
EPS
-$0.55
Free cash flow per share
$0.65
Book value per share
$10.14
Revenue per share
$22.79
TBVPS
$9.26
Balance sheet
Total assets
$2.34B
Total liabilities
$1.46B
Debt
$869.21M
Equity
$877.08M
Working capital
$170.05M
Liquidity
Debt to equity
0.99
Current ratio
1.63
Quick ratio
1.54
Net debt/EBITDA
4.05
Margins
EBITDA margin
10.9%
Gross margin
26.6%
Net margin
4.7%
Operating margin
11.1%
Efficiency
Return on assets
3.6%
Return on equity
10.8%
Return on invested capital
12.7%
Return on capital employed
8.7%
Return on sales
9.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
3.45%
1 week
9.91%
1 month
14.78%
1 year
-33.64%
YTD
-22.93%
QTD
-10.69%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.95B
Gross profit
$518.3M
Operating income
$215.92M
Net income
$92.13M
Gross margin
26.6%
Net margin
4.7%
The net income has surged by 112% year-on-year but it has declined by 30% since the previous quarter
The net margin has soared by 111% YoY but it has decreased by 32% from the previous quarter
MD's operating income has surged by 90% year-on-year and by 6% since the previous quarter
The operating margin has surged by 71% year-on-year and by 4.7% since the previous quarter

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
N/A
P/B
2.07
P/S
0.92
EV/EBIT
14.97
EV/EBITDA
12.66
EV/Sales
1.38
The company's EPS has surged by 94% YoY
The P/B is 26% below the last 4 quarters average of 2.8 but 15% above the 5-year quarterly average of 1.8
The equity is up by 14% YoY but it is down by 2.2% QoQ
The stock's price to sales (P/S) is 29% less than its 5-year quarterly average of 1.3 and 23% less than its last 4 quarters average of 1.2
The revenue has increased by 12% YoY

Efficiency

How efficient is Mednax business performance
The ROIC has soared by 143% YoY but it is down by 20% from the previous quarter
The company's return on sales has surged by 125% YoY but it fell by 23% QoQ
The ROA has soared by 115% YoY but it has contracted by 28% from the previous quarter
MD's return on equity has surged by 111% year-on-year but it is down by 32% since the previous quarter

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 60% greater than the total liabilities
The company's current ratio fell by 20% YoY and by 17% QoQ
The total liabilities has declined by 20% since the previous quarter and by 15% year-on-year
MD's debt to equity is down by 28% year-on-year and by 17% since the previous quarter
The debt has decreased by 18% from the previous quarter and by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.